Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Total Shareholders' Equity	Total Shareholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Preferred Shares	Common Shares	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Distributions in Excess of Retained Earnings	Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2020					20,400,000	130,673,300
Beginning balance at Dec. 31, 2020	$ 3,264,326	$ (113,099)	$ 3,257,337	$ (113,099)	$ 204	$ 1,307	$ 4,169,870	$ (113,099)	$ (60,071)	$ (853,973)	$ 6,989
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemption of preferred shares (in shares)					(10,000,000)
Redemption of preferred shares	(250,000)		(250,000)		$ (100)		(241,845)			(8,055)
Issuance of shares, net of offering costs (in shares)					19,200,000
Issuance of shares, net of offering costs	464,054		464,054		$ 192		463,862
Issuance of common shares for Board of Trustees compensation (in shares)						27,711
Issuance of common shares for Board of Trustees compensation	516		516			$ 1	515
Repurchase of common shares (in shares)						(38,310)
Repurchase of common shares	(720)		(720)			$ (1)	(719)
Share-based compensation (in shares)						151,049
Share-based compensation	12,879		10,434			$ 1	10,433				2,445
Distributions on common shares/units	(5,098)		(5,032)							(5,032)	(66)
Distributions on preferred shares/units	(42,105)		(42,105)							(42,105)	0
Purchases of capped calls in connection with convertible senior notes	(20,975)		(20,975)				(20,975)
Other adjustment	0		393						393		(393)
Other comprehensive income (loss):
Change in fair value of derivative instruments	15,289		15,026						15,026		263
Amounts reclassified from other comprehensive income	25,210		25,210						25,210
Net income (loss)	(186,372)		(184,858)							(184,858)	(1,514)
Ending balance (in shares) at Dec. 31, 2021					29,600,000	130,813,750
Ending balance at Dec. 31, 2021	3,163,905		3,156,181		$ 296	$ 1,308	4,268,042		(19,442)	(1,094,023)	7,724
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemption of preferred shares (in shares)					(1,000,000)
Redemption of preferred shares	(16,000)		(16,000)		$ (10)		(24,176)			8,186
Issuance of shares, net of offering costs (in shares)					0
Issuance of shares, net of offering costs	(123)		(123)		$ 0		(123)
Issuance of operating partnership units	78,000										78,000
Issuance of common shares for Board of Trustees compensation (in shares)						33,866
Issuance of common shares for Board of Trustees compensation	738		738			$ 1	737
Repurchase of common shares (in shares)						(4,609,626)
Repurchase of common shares	(70,724)		(70,724)			$ (47)	(70,677)
Share-based compensation (in shares)						107,303
Share-based compensation	11,350		8,557			$ 1	8,556				2,793
Distributions on common shares/units	(5,104)		(5,035)							(5,035)	(69)
Distributions on preferred shares/units	(48,049)		(45,074)							(45,074)	(2,975)
Other comprehensive income (loss):
Change in fair value of derivative instruments	55,479		55,114						55,114		365
Amounts reclassified from other comprehensive income	52		52						52
Net income (loss)	(84,981)		(87,171)							(87,171)	2,190
Ending balance (in shares) at Dec. 31, 2022					28,600,000	126,345,293
Ending balance at Dec. 31, 2022	3,084,543		2,996,515		$ 286	$ 1,263	4,182,359		35,724	(1,223,117)	88,028
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemption of preferred shares (in shares)					(1,000,000)
Redemption of preferred shares	(15,790)		(15,790)		$ (10)		(24,176)			8,396
Redemption of non-controlling interest OP units (in shares)						133,605
Redemption of non-controlling interests			3,515			$ 1	3,514				(3,515)
Issuance of common shares for Board of Trustees compensation (in shares)						55,480
Issuance of common shares for Board of Trustees compensation	754		754			$ 1	753
Repurchase of common shares (in shares)						(6,578,436)
Repurchase of common shares	(92,753)		(92,753)			$ (65)	(92,688)
Share-based compensation (in shares)						235,407
Share-based compensation	12,545		9,152			$ 2	9,150				3,393
Distributions on common shares/units	(4,949)		(4,877)							(4,877)	(72)
Distributions on preferred shares/units	(48,306)		(43,649)							(43,649)	(4,657)
Other comprehensive income (loss):
Change in fair value of derivative instruments	17,572		17,645						17,645		(73)
Amounts reclassified from other comprehensive income	(28,995)		(28,995)						(28,995)
Net income (loss)	(74,276)		(78,017)							(78,017)	3,741
Ending balance (in shares) at Dec. 31, 2023					27,600,000	120,191,349
Ending balance at Dec. 31, 2023	$ 2,850,345		$ 2,763,500		$ 276	$ 1,202	$ 4,078,912		$ 24,374	$ (1,341,264)	$ 86,845